2022 Annual Meeting

(693c) Plasmidmaker: A Versatile, Automated, and High Throughput End-to-End Platform for Plasmid Construction

Authors

Behnam Enghiad - Presenter, University of Illinois at Urbana-Champaign
Pu Xue, University of Illinois At Urbana Champaign
Nilmani Singh, Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign
Chengyou Shi, University of Illinois, Urbana Champaign
Vassily Andrew Petrov, University of Illinois at Urbana-Champaign
Roy Liu, University of Illinois Urbana-Champaign
Siddhartha Suryanarayana Peri, University of Illinois Urbana-Champaign
Stephan Thomas Lane, University of Illinois at Urbana-Champaign
Huimin Zhao, University of Illinois-Urbana
Plasmids are used extensively in basic and applied biology. However, design and construction of plasmids, specifically the ones carrying complex genetic information, remains one of the most time-consuming, labor-intensive, and rate-limiting steps in performing sophisticated biological experiments. We report a robust, versatile, and automated end-to-end platform for plasmid construction named PlasmidMaker that enables scarless and error-free construction of virtually any plasmids in a high throughput manner. To implement this platform, we first developed a versatile, scarless, parallel, robust, and accurate method for assembly of multiple DNA fragments using Pyrococcus furiosus Argonaute (PfAgo) based artificial restriction enzymes (AREs). We then created a user-friendly frontend for plasmid design, and a backend that streamlines the workflow. Finally, we integrated the DNA assembly method and the software with a robotic system named Illinois Biological Foundry for Advanced Biomanufatcuring (iBioFAB) to create a nearly fully automated workflow. As a proof of concept, we used this platform to construct 101 plasmids across 6 different species (bacteria, yeast, plants, and mammals) which involves ~2×104 pipetting steps. Plasmids with sizes ranging from 5 to 18 kb were assembled from up to 11 DNA fragments efficiently with limited human intervention. PlasmidMaker should greatly expand the potential of synthetic biology.